发明公开
- 专利标题： A NOVEL PROTEOSOME-LIPOSACCHARIDE VACCINE ADJUVANT
- 专利标题（中）： 蛋白酶体脂多糖，疫苗佐剂
-
申请号： EP02713807.2申请日： 2002-03-11
-
公开(公告)号： EP1372706A2公开(公告)日： 2004-01-02
- 发明人: BURT, David, S. , LOWELL, George, H. , WHITE, Gregory, L. , JONES, David , RIOUX, Clement
- 申请人： ID Biomedical Corporation of Quebec , Jones, David
- 申请人地址： 7150 Frederick Banting,Suite 200 Ville St. Laurent,Québec H4S 2A1 CA
- 专利权人： ID Biomedical Corporation of Quebec,Jones, David
- 当前专利权人： ID Biomedical Corporation of Quebec,Jones, David
- 当前专利权人地址： 7150 Frederick Banting,Suite 200 Ville St. Laurent,Québec H4S 2A1 CA
- 代理机构： Wright, Simon Mark
- 优先权： US274232P 20010309; US327297P 20011009
- 国际公布： WO2002072012 20020919
- 主分类号： A61K39/02
- IPC分类号： A61K39/02 ; A61K39/108 ; A61K39/12 ; A61K39/095 ; A61K39/116 ; A61K39/385 ; C07H1/00 ; C07K1/00
摘要：
An adjuvant complex composed of bacterial outer membrane protein proteosomes complexed to bacterial liposaccharide is prepared to contain the component parts under a variety of conditions. The complex can be formulated with antigenic material to form immunogenic compositions, vaccines and immunotherapeutics. An induced immune response includes protective antibodies and/or type 1 cytokines is shown for a variety of protocols.
公开/授权文献
- EP1372706B1 PROTEOSOME-LIPOSACCHARIDE VACCINE ADJUVANT 公开/授权日：2010-12-01
信息查询
